6OB7
Human equilibrative nucleoside transporter-1, dilazep bound
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 24-ID-C |
Synchrotron site | APS |
Beamline | 24-ID-C |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2018-07-20 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.979 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 72.040, 72.040, 173.371 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 62.388 - 2.300 |
R-factor | 0.2054 |
Rwork | 0.203 |
R-free | 0.24270 |
Structure solution method | SIRAS |
RMSD bond length | 0.006 |
RMSD bond angle | 0.868 |
Data reduction software | MOSFLM |
Data scaling software | Aimless |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 62.390 | 2.380 |
High resolution limit [Å] | 2.300 | 2.300 |
Rpim | 0.110 | 0.560 |
Number of reflections | 22877 | 2236 |
<I/σ(I)> | 6 | 1.4 |
Completeness [%] | 91.8 | 82.4 |
Redundancy | 4.6 | 4.1 |
CC(1/2) | 0.990 | 0.390 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 9 | 298 | 50% PEG 400, 0.5 M NaCl, 0.1 M glycine pH 9.0 |